Dna X (SONM) EBT (2018 - 2026)

Dna X (SONM) has 9 years of EBT data on file, last reported at -$3.9 million in Q1 2026.

• Quarterly EBT fell 308.74% year-over-year to -$3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.5 million (down 1073.38% YoY) and the FY2025 annual result came in at -$8.0 million, down 175.93% from the prior year.
• EBT retreated to -$3.9 million in Q1 2026, from $3.5 million in the prior quarter.
• In the past five years, EBT ranged from a high of $12.8 million in Q4 2022 to a low of -$7.3 million in Q2 2025.
• A 5-year average of -$944176.5 and a median of -$1.5 million in 2022 frame the typical range for EBT.
• The widest YoY moves for EBT: up 804.13% in 2024, down 1232.36% in 2024.
• Tracing SONM's EBT over 5 years: stood at $12.8 million in 2022, then plunged by 109.82% to -$1.3 million in 2023, then soared by 804.13% to $8.9 million in 2024, then slumped by 61.07% to $3.5 million in 2025, then sank by 213.72% to -$3.9 million in 2026.
• The last three EBT figures came in at -$3.9 million (Q1 2026), $3.5 million (Q4 2025), and -$4.7 million (Q3 2025), per Business Quant data.